The two main checkpoints currently targeted in melanoma are cytotoxic-T-lymphocyte-associated protein 4 (CTLA-4), programmed death-protein 1 (PD-1), and programmed death-ligand 1 (PD-L1) [54]. The gene discussed is CTLA4; the disease is melanoma.